文献速递造血干细胞移植与细胞治疗白血病MDS 与骨髓增殖性肿瘤

评估用于因血液系统恶性肿瘤接受脐带血移植的成人患者的疾病风险指数

Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies.
PubMed 文献 · Br J Haematol · 2017-10-19

该研究回顾性分析了2004至2014年间接受无关脐带血移植的2530例成人患者,评估疾病风险指数(DRI)的适用性。2年总生存率在低危组为56±3%、中危组46±1%、高危组28±2%、极高危组20±4%(P<0·001)。多因素模型中DRI仍为总生存的独立危险因素,无进展生存也观察到类似结果,表明DRI可用于对脐带血移植受者进行分层。

要点

  • DRI将脐带血移植患者分为低、中、高、极高危四组,2年总生存率分别为56±3%、46±1%、28±2%、20±4%。
  • 多因素分析显示DRI是总生存的独立危险因素,无进展生存也观察到类似结果。
  • DRI这一简单而稳健的工具在脐带血移植中具有预后价值。

核心结论

  • DRI适用于对接受无关脐带血移植的成人患者进行分层,并证实其在该场景下具有预后价值。

研究设计与样本

  • 回顾性分析2004年至2014年间接受无关脐带血移植的2530例成人患者,其中急性白血病占66%。

主要发现

  • 2年总生存率:低DRI组(n=352)56±3%,中DRI组(n=1403)46±1%,高DRI组(n=489)28±2%,极高DRI组(n=109)20±4%(P<0·001)。
  • 多因素模型中DRI仍为总生存的独立危险因素;无进展生存也观察到与DRI类似的结果。

关键数值与推荐

  • DRI将患者分为4个不同结局的组,分组依据疾病类型和状态,并考虑急性髓系白血病和骨髓增生异常综合征(MDS)的细胞遗传学。
  • DRI近期已 refined 以纳入罕见疾病,并通过原始细胞百分比和对既往治疗的反应改进MDS分层。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A disease risk index (DRI) has been defined for stratifying heterogeneous cohorts of patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT). This index defines 4 distinct groups with different outcomes, dividing patients by disease type and status and considering cytogenetics for acute myeloid leukaemia and myelodysplastic syndromes (MDS). Recently, the DRI has been refined to include rare diseases and improve MDS stratification by blast percentage and response to prior therapy. Previous reports on DRI include only a small number of UCBT recipients. The current study aims to determine the applicability of the DRI for patients undergoing unrelated cord blood transplantation (UCBT). We retrospectively analysed 2530 adults receiving UCBT between 2004 and 2014. Diagnosis was acute leukaemia (AL) in 66% of the cases. Overall survival (OS) at 2 years was 56 ± 3% for patients with low DRI (n = 352), 46 ± 1% for intermediate DRI (n = 1403), 28 ± 2% for high (n = 489) and 20 ± 4% for very high DRI (n = 109) (P < 0·001). In the multivariate model, DRI remained an independent risk factor for OS. Similar findings were observed for PFS and DRI. Our results show the applicability of DRI for stratifying UCBT recipients and confirm the prognostic value of this simple and robust tool in this setting.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Paviglianiti A, Ruggeri A, Volt F, et al. Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies. Br J Haematol. 2017. PMID: 29048109. doi:10.1111/bjh.14962

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。